261 related articles for article (PubMed ID: 1819436)
1. [A new combined vaccine against yellow fever and measles in infants aged 6 to 24 months in Mali].
Soula G; Sylla A; Pichard E; Kodio B; Bentejac MC; Teulières L; Saliou P
Bull Soc Pathol Exot; 1991; 84(5 Pt 5):885-97. PubMed ID: 1819436
[TBL] [Abstract][Full Text] [Related]
2. [The combined measles-yellow fever vaccination in African infants aged 6 to 10 months].
Mouchon D; Pignon D; Vicens R; Tu-Ha-Thanh ; Tekaia F; Teulières L; Garrigue G
Bull Soc Pathol Exot; 1990; 83(4):537-51. PubMed ID: 2286007
[TBL] [Abstract][Full Text] [Related]
3. Field trial of combined yellow fever and measles vaccines among children in Nigeria.
Adu FD; Omotade OO; Oyedele OI; Ikusika O; Odemuyiwa SO; Onoja AL
East Afr Med J; 1996 Sep; 73(9):579-82. PubMed ID: 8991237
[TBL] [Abstract][Full Text] [Related]
4. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
[TBL] [Abstract][Full Text] [Related]
5. Antibody response after measles immunization.
Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program.
Collaborative Group for Studies with Yellow Fever Vaccine
Vaccine; 2007 Apr; 25(16):3118-23. PubMed ID: 17316925
[TBL] [Abstract][Full Text] [Related]
7. Seroconversion after measles vaccination at nine and fifteen months of age.
Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
[TBL] [Abstract][Full Text] [Related]
8. Study of combined vaccination against yellow fever and measles in infants from six to nine months.
Lhuillier M; Mazzariol MJ; Zadi S; Le Cam N; Bentejac MC; Adamowicz L; Marie FN; Fritzell B
J Biol Stand; 1989 Jan; 17(1):9-15. PubMed ID: 2537830
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a combined measles-mumps-rubella-chickenpox vaccine.
Just M; Berger R; Just V
Dev Biol Stand; 1986; 65():85-8. PubMed ID: 3030863
[TBL] [Abstract][Full Text] [Related]
10. EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia.
Viviani S; Mendy M; Jack AD; Hall AJ; Montesano R; Whittle HC
Trop Med Int Health; 2004 Oct; 9(10):1044-9. PubMed ID: 15482396
[TBL] [Abstract][Full Text] [Related]
11. Immune response to Edmonston-Zagreb measles virus strain in monovalent and combined MMR vaccine.
Beck M; Smerdel S; Dedić I; Delimar N; Rajninger-Miholic M; Juzbasić M; Manhalter T; Vlatković R; Borcić B; Mihajić Z
Dev Biol Stand; 1986; 65():95-100. PubMed ID: 3556780
[TBL] [Abstract][Full Text] [Related]
12. Recent immunization against measles does not interfere with the sero-response to yellow fever vaccine.
Stefano I; Sato HK; Pannuti CS; Omoto TM; Mann G; Freire MS; Yamamura AM; Vasconcelos PF; Oselka GW; Weckx LW; Salgado MF; Noale LF; Souza VA
Vaccine; 1999 Mar; 17(9-10):1042-6. PubMed ID: 10195613
[TBL] [Abstract][Full Text] [Related]
13. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
[TBL] [Abstract][Full Text] [Related]
14. Combined vaccine against measles, mumps, rubella, and varicella.
Brunell PA; Novelli VM; Lipton SV; Pollock B
Pediatrics; 1988 Jun; 81(6):779-84. PubMed ID: 2835743
[TBL] [Abstract][Full Text] [Related]
15. Gender differences in the reactogenicity of measles-mumps-rubella vaccine.
Shohat T; Green MS; Nakar O; Ballin A; Duvdevani P; Cohen A; Shohat M
Isr Med Assoc J; 2000 Mar; 2(3):192-5. PubMed ID: 10774264
[TBL] [Abstract][Full Text] [Related]
16. Immune responses to measles immunization and the impacts on HIV-infected children.
Thaithumyanon P; Punnahitananda S; Thisyakorn U; Praisuwanna P; Ruxrungtham K
Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):658-62. PubMed ID: 11414407
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.
Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL
Vaccine; 2006 Jan; 24(5):683-90. PubMed ID: 16154241
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age.
Goh P; Lim FS; Han HH; Willems P
Infection; 2007 Oct; 35(5):326-33. PubMed ID: 17710370
[TBL] [Abstract][Full Text] [Related]
19. [Comparative serological efficacy of the measles vaccine strains Edmonston-Zagreb, Schwarz and AIK-C in Togolese infants of 4-5 months and 8-10 months].
Tidjani O; Grunitzky B; Guérin N; Lévy-Bruhl D; Lecam N; Xuereff C; Tatagan K
Bull Soc Pathol Exot; 1991; 84(5 Pt 5):873-84. PubMed ID: 1819435
[TBL] [Abstract][Full Text] [Related]
20. Seroconversion rates and measles antibody titers induced by measles vaccination in Latin American children six to 12 months of age.
Rev Infect Dis; 1983; 5(3):596-605. PubMed ID: 6879022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
